- Home
- KROS vs ALLT Comparison
KROS vs ALLT Comparison
Compare KROS & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | ALLT |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 519.6M |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | KROS | ALLT |
|---|---|---|
| Price | $16.57 | $10.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $23.00 | $13.25 |
| AVG Volume (30 Days) | 266.1K | ★ 323.8K |
| Earning Date | 03-03-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.57 | 0.02 |
| Revenue | ★ $246,718,000.00 | $98,512,000.00 |
| Revenue This Year | $6,924.79 | $12.28 |
| Revenue Next Year | N/A | $12.95 |
| P/E Ratio | ★ $10.53 | $476.17 |
| Revenue Growth | ★ 37798.31 | 7.51 |
| 52 Week Low | $9.12 | $4.37 |
| 52 Week High | $22.55 | $11.92 |
Technical Indicators
Market Signals| Indicator | KROS | ALLT |
|---|---|---|
| Relative Strength Index (RSI) | 36.19 | 51.33 |
| Support Level | $16.31 | $9.80 |
| Resistance Level | $17.17 | $10.79 |
| Average True Range (ATR) | 0.63 | 0.53 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 18.26 | 58.81 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.